Pregunta:
•Inhibit T-cell activation •MOA: COMPETES with CD28 for binding on CD80/CD86 protein, thereby PREVENTING FULL T-CELL ACTIVATION (given IV EVERY 4 WEEKS)
Autor: LEIGHTON DWIGHT OBILLOSRespuesta:
ABATACEPT
0 / 5 (0 calificaciones)
1 answer(s) in total
